Tom 13, Nr 4 (2016)
Wytyczne / stanowisko ekspertów
Opublikowany online: 2016-11-30
Wyświetlenia strony
1047
Wyświetlenia/pobrania artykułu
23510
Niesteroidowe leki przeciwzapalne a powikłania sercowo-naczyniowe i gastroenterologiczne — algorytm wyboru
Choroby Serca i Naczyń 2016;13(4):257-264.
Streszczenie
Brak
Słowa kluczowe: niesteroidowe leki przeciwzapalnepowikłania gastroenterologicznepowikłania sercowo-naczyniowe
Referencje
- Antman EM, Bennett JS, Daugherty A, et al. American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007; 115(12): 1634–1642.
- Avanzini F, Palumbo G, Alli C, et al. Effects of low-dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)--Hypertension study. Am J Hypertens. 2000; 13(6 Pt 1): 611–616.
- Burmester G, Lanas A, Biasucci L, et al. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis. 2011; 70(5): 818–822.
- Castellsague J, Riera-Guardia N, Calingaert B, et al. Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012; 35(12): 1127–1146.
- Catella-Lawson F, McAdam B, Morrison BW, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 1999; 289(2): 735–741.
- Conlin PR, Moore TJ, Swartz SL, et al. Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients. Hypertension. 2000; 36(3): 461–465.
- Bhala N, Emberson J, Merhi A, et al. Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013; 382(9894): 769–779.
- Farkouh ME, Greenberg BP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol. 2009; 103(9): 1227–1237.
- Filipiak KJ. koksyby, celekoksyb — czy kardiolodzy są wyznawcami „odpowiedzialności zbiorowej”? Choroby Serca Nacz. 2012; 9: 135–136.
- Filipiak KJ, Niewada M. Stosowanie niesteroidowych leków przeciwzapalnych w praktyce kardiologicznej. In: Kucharz EJ. ed. Zasady postępowania dotyczące leczenia NLPZ. Komunikacja reumatolog– –pacjent–lekarz rodzinny. ER Medical, Warszawa 2014.
- Fogari R, Zoppi A, Carretta R, et al. Italian Collaborative Study Group. Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study. J Hypertens. 2002; 20(5): 1007–1014.
- Friedewald VE, Bennett JS, Christo JP, et al. AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol. 2010; 106(6): 873–884.
- Gargiulo G, Capodanno D, Longo G, et al. Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes. Expert Rev Cardiovasc Ther. 2014; 12(10): 1185–1203.
- Hohlfeld T, Saxena A, Schrör K. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance. Thromb Haemost. 2013; 109(5): 825–833.
- Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994; 121(4): 289–300.
- Krum H, Swergold G, Curtis SP, et al. Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study. J Hypertens. 2009; 27(4): 886–893.
- Laporte JR, Ibáñez L, Vidal X, et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf. 2004; 27(6): 411–420.
- Morgan T, Anderson A. Interaction of indomethacin with felodipine and enalapril. J Hypertens Suppl. 1993; 11(5): S338–S339.
- Morgan TO, Anderson A, Bertram D. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. American Journal of Hypertension. 2000; 13(11): 1161–1167.
- Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999; 79(4): 1193–1226.
- Palmer R, Weiss R, Zusman RM, et al. Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors. Am J Hypertens. 2003; 16(2): 135–139.
- Rahman M, Wright JT, Douglas JG. The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review. Am J Hypertens. 1997; 10(3): 356–365.
- Samborski W, Filipiak KJ, Kierzkiewicz M, et al. Wybór NLPZ a powikłania gastroenterologiczne i sercowo-naczyniowe — stanowisko ekspertów. Forum Med. Rodz. 2015. 2015; 9(supl. B): 1–13.
- Saxena A, Balaramnavar VM, Hohlfeld T, et al. Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets. Eur J Pharmacol. 2013; 721(1-3): 215–224.
- Whelton A, White WB, Bello AE, et al. SUCCESS-VII Investigators. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol. 2002; 90(9): 959–963.
- Zanchetti A, Hansson L, Leonetti G, et al. Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. Journal of Hypertension. 2002; 20(5): 1015–1022.
